Schnitzler Syndrome

This is a very rare condition. It causes a combination of symptoms like skin rashes, fever, bone pain, and high blood counts. It's caused by a specific type of protein in the blood that doesn't work correctly.

Condition

What people with Schnitzler Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Interleukin 1 Receptor Antagonist Protein for Schnitzler Syndrome?

NameHow it went

About Schnitzler Syndrome

What It Is

Schnitzler syndrome is a rare, long-lasting inflammatory disease that usually begins in middle age. Its hallmark is a recurring rash that looks like hives, together with an abnormal antibody protein in the blood called a monoclonal protein, most often of the IgM type. Most people also have repeated fevers, tiredness, and aching in the bones and joints, especially the shins, thighs and hips. The rash differs from ordinary hives in useful ways. It is usually not itchy or only mildly so, individual spots fade within a day without leaving marks, and antihistamines do not help. Because each symptom on its own is common, the condition is often recognized only after years of investigation. Without treatment, the ongoing inflammation can seriously affect energy, work and quality of life.

Causes & Risk Factors

Schnitzler syndrome is not inherited and is not caused by anything a person did. It is classed as an acquired autoinflammatory disease: the innate immune system, the body's first-line defense, becomes overactive and releases too much of a signaling protein called interleukin-1 (IL-1), which drives fever, rash and bone pain. Why this happens, and how it connects to the abnormal blood protein, is still not understood. The main risk factor is age. Symptoms typically start around 50 to 55, onset before 35 is very unusual, and men are affected slightly more often than women. There are no known everyday triggers to avoid, although individual flares can come and go without a clear pattern.

How It's Diagnosed

No single test confirms Schnitzler syndrome. Doctors use agreed criteria: a chronic hive-like rash and a monoclonal IgM or IgG protein must both be present, plus additional signs such as unexplained recurring fever above 38 °C (100.4 °F), evidence of abnormal bone activity, a characteristic pattern on skin biopsy, or markedly raised inflammation in blood tests. With an IgG protein, more of these extra signs are needed. Testing usually includes protein electrophoresis and immunofixation, blood tests that detect and identify a monoclonal protein, along with C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), two general markers of inflammation that are almost always raised. A skin biopsy can show a pattern of white blood cells called neutrophilic urticarial dermatosis. Bone scans or MRI can show areas of thickened, overactive bone, often around the knees. Because chronic hives and monoclonal proteins are each fairly common in older adults, specialists are careful not to label someone with Schnitzler syndrome unless the full picture fits. Other conditions considered include urticarial vasculitis, adult-onset Still's disease and inherited fever syndromes. A rapid response to IL-1 blocking treatment supports the diagnosis; no response is a reason to look again.

Treatment Options

Treatment aims to switch off the inflammation and, with it, the rash, fever and pain. Medicines that block IL-1 are the first choice and work remarkably well for most people. They are used off label, meaning they are FDA approved for other inflammatory diseases but not specifically for Schnitzler syndrome, which can affect insurance approval. Anakinra (Kineret) is the most widely used. It is injected under the skin, usually daily or every other day, and many people notice symptoms clearing within hours to a couple of days. The effect wears off quickly, so symptoms usually return within one to two days if treatment stops. Injection-site reactions are common, and blood counts are checked because anakinra can lower white blood cells. Canakinumab (Ilaris), an antibody against IL-1, has been tested in a small placebo-controlled trial and needs injections only every few weeks or months, but it costs much more and lasts longer in the body if a problem arises. Rilonacept (Arcalyst) is another option studied in a small number of patients. Colchicine, an older anti-inflammatory pill, helps some people with mild disease or can be added when an IL-1 blocker is not fully effective. Before IL-1 blockers, only long-term high-dose steroids reliably controlled symptoms, at the cost of serious side effects. For the rare person who does not respond, specialists may try medicines such as tocilizumab, which blocks a different inflammatory signal. Treatment controls symptoms but does not remove the abnormal blood protein.

What to Expect

Schnitzler syndrome is a long-term condition. Lasting spontaneous remission is extremely rare, so most people need ongoing treatment. With an IL-1 blocker, many people return to a largely normal daily life, though daily injections become part of the routine. Controlling inflammation also helps prevent AA amyloidosis, a rare buildup of inflammatory protein in organs such as the kidneys that has occurred after years of untreated disease. The most important long-term issue is the abnormal blood protein. Over time, some people develop a blood cancer, most often Waldenström macroglobulinemia, a slow-growing lymphoma. In published cases about 1 in 8 people developed one over a median of eight years, and the true figure may be higher. Treatment for symptoms does not lower this risk, so regular follow-up with blood tests to track the protein and a physical exam for lymph nodes continues even when someone feels well. Care is often shared between a rheumatologist or dermatologist and a hematologist.

When to Seek Help

Ask for an evaluation, ideally by a rheumatologist or dermatologist familiar with autoinflammatory disease, if you have a hive-like rash that keeps returning for months, does not respond to antihistamines, and comes with fevers, bone pain or fatigue. If you already have the diagnosis, contact your care team promptly if symptoms return despite treatment, or if you notice new or growing lymph nodes or unexplained weight loss, since these can signal a change in the blood protein. People taking an IL-1 blocker should also call about fever or other signs of infection, as the treatment can blunt the body's response to infection.

Questions to Ask Your Doctor

  1. 1.Do my test results meet the criteria for Schnitzler syndrome, or could something else explain my symptoms?
  2. 2.Which treatment do you recommend for me, and how will we know quickly whether it is working?
  3. 3.How often should my monoclonal protein and blood counts be checked, and which specialists should be involved?
  4. 4.What will insurance require for an off-label IL-1 blocker, and what are the options if coverage is denied?
  5. 5.Which new symptoms should prompt me to contact you between visits?

Last reviewed • Oct 2026

Educational content, not medical advice.